首页> 外国专利> Bifidobacterium lactis Bb-12 in primary prevention of atopic diseases

Bifidobacterium lactis Bb-12 in primary prevention of atopic diseases

机译：乳酸双歧杆菌Bb-12在特应性疾病的一级预防中

页面导航

摘要
著录项
相似文献

摘要

The present invention is in the field of prophylaxis of allergies, and relates specifically to primary prevention of atopic diseases by administering probiotic bifidobacteria, beneficial microbes of the healthy gut flora, to children at high risk of atopic diseases.

机译：本发明属于过敏症的预防领域，特别涉及对高风险的儿童进行益生性双歧杆菌，健康的肠道菌群的有益微生物的一级预防。

著录项

公开/公告号EP2201955B1

专利类型
公开/公告日2019-08-14

原文格式PDF
申请/专利权人 SOCIÉTÉ DES PRODUITS NESTLÉ S.A.;
展开▼

申请/专利号EP20090164284
发明设计人 ISOLAURI ERIKA;SALMINEN SEPPO;
展开▼

申请日2001-06-20
分类号A61K35/745;A61P37/08;
国家 EP
入库时间 2022-08-21 12:31:38

相似文献

专利
外文文献
中文文献

1. Nursing service quality,availability,accessibility and acceptability in communicable and chronic diseases prevention and treatment as well as in the primary health care [J] . T.Dileep Kumar 国际护理科学（英文） . 2017,第004期

2. Nursing service quality,availability,accessibility and acceptability in communicable and chronic diseases prevention and treatment as well as in the primary health care [J] . Dra.Mirna Frota 国际护理科学（英文） . 2017,第004期

3. Nursing service quality,availability,accessibility and acceptability in communicable and chronic diseases prevention and treatment as well as in the primary health care [J] . Simon Hlungwani 国际护理科学（英文） . 2017,第004期

4. Nursing service quality, availability, accessibility and acceptability in communicable and chronic diseases prevention and treatment as well as in the primary health care [J] . T. Dileep Kumar 国际护理科学（英文） . 2017,第004期

5. Fermentation of Honey-Sweetened Soymilk with Bifidobacterium lactis Bb-12 and Bifidobacterium longum Bb-46: Fermentation Activity of Bifidobacteria and in vitro Antagonistic Effect against Listeria monocytogenes FSL Nl-017 [J] . Vedran SLACANAC, Mirela LUCAN, Jovica HARDI, Czech Journal of Food Sciences . 2012,第4期

6. Fermentation of honey-sweetened soymilk with Bifidobacterium lactis Bb-12 and Bifidobacterium longum Bb-46: fermentation activity of bifidobacteria and in vitro antagonistic effect against Listeria monocytogenes FSL N1-017 [J] . Czech Journal of Food Sciences . 2012,第4期

7. Application of microencapsulated probiotic Bifidobacterium animalis ssp. lactis BB-12 in Italian salami [J] . Brenda de Oliveira Gomes, Catarina de Mesquita Oliveira, Annecler Rech de Marins, Journal of Food Processing and Preservation . 2021,第10期

8. A Comparative Study of AI-based Predictive Models for Cardiovascular Disease (CVD) Prevention in Next Generation Primary Healthcare Services [C] . Tannishtha Mandal, Sougata Bera, Debashis Saha IEEE International Conference for Innovation in Technology . 2020

9. A study on the effect of delivery vehicles on the efficacy of Bifidobacterium animalis subsp. lactis BB-12 in humans. [D] . Ba, Zhaoyong. 2016

10. Impact of Body Mass Index (BMI) on the Effect of a Lactobacillus Rhamnosus GG (LGG)/Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) Combination on Gut Microbiota (P20-023-19) [O] . Debra Poutsiaka, Lori Stern, Virginia Riquelme, 2019

11. Combination of the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled Trial [O] . Vivian M. Castro-Herrera, Helena L. Fisk, Mandy Wootton, 2021

1. Charge Transport in Bifidobacterium animalis subsp.lactis BB-12 under Various Atmospheres [J] . K.Bozkurt ,C.Denktas ,O.Ozdemir . 应用科学（英文） . 2019,第6期

2. 他汀类药物在心血管疾病一级预防中的研究回顾 [C] . 李建军 . 长沙血脂论坛2014年会 . 2014

3. 他汀及阿司匹林在心血管疾病一级预防中的研究进展 [A] . 何斌 . 2020